Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 19.91 BATS BZX Real-Time Price As of 3:39pm ET |  -0.19 / -0.95%Today’s Change | 18.84 Today|||52-Week Range 33.49 | -32.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2017 | Quarter 1 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 663.9K | 2.8M | 1.0M | 6.5M | |
| Depreciation And Amortization | 105.4K | 167.1K | 182.5K | 215.3K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 6.6M | 5.6M | 8.7M | 9.6M | ||
| Research And Development | 4.5M | 3.7M | 6.5M | 6.3M | ||
| Total Operating Expenses | 6.7M | 5.7M | 8.9M | 9.8M | ||
| Non-Operating Expenses | Operating Income | -6.0M | -2.9M | -7.8M | -3.3M | |
| Extraordinary Charge | 0.00 | -38.3K | -468.1K | -3.2M | ||
| Other Expenses | -405.5K | -3.0K | 99.2K | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -6.4M | -2.9M | -8.1M | -6.5M | |
| Income Taxes | -79.1K | -398.7K | -189.4K | -80.9K | ||
| Net Income | -6.5M | -2.6M | -7.9M | -6.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 17.7M | 17.7M | 17.7M | 13.3M | |
| Shares To Calculate EPS Diluted | 17.7M | 17.7M | 17.7M | 13.3M | ||
| Earnings Per Share | EPS | -$0.37 | -$0.14 | -$0.45 | -$0.49 | |
| EPS Diluted | -$0.37 | -$0.14 | -$0.45 | -$0.49 | ||
